All products / DC20764
BDP9066
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $850 USDRequest a quote / confirm availability → |
| 250 mg | $1,700 USDRequest a quote / confirm availability → |
| 1 g | $3,400 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
BDP9066 (BDP-9066) is a highly potent and selective Myotonic dystrophy-related Cdc42-binding kinase MRCK inhibitor with IC50 of 43 nM, >100-fold selectivity over related ROCK1 or ROCK2; shows similar activity against MRCKα and MRCKβ; inhibits MLC2 phosphorylation (EC50=64 nM) and blocks SCC12 squamous cell carcinoma motility and invasion; reduces MRCKα S1003 autophosphorylation and skin papilloma outgrowth in chemical carcinogenesis model of murine squamous cell carcinoma.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC20764 |
|---|---|
| Product name | BDP9066 |
| CAS | 2226507-04-4 |
| Molecular formula | C20H24N6 |
| Molecular weight | 348.44 |
| Purity | >98% |
| SMILES | c1cc(-c2cnc3[nH]ccc(N4CCC[C@@]5(CCCCN5)C4)c2-3)ncn1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — BDP9066 (DC20764)